# US 2021/0276959 A1 · Process for preparing 4-amino-pyridazines

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0276959 A1
- Document ID: US20210276959A1
- Status: Published application
- Kind: A1
- Application number: 17/323,337
- Filed: 2021-05-18
- Published: 2021-09-09
- Earliest claimed: 2015-05-11
- Assignees: BASF SE
- Applicants: BASF SE
- Inventors: Eric George Klauber; Michael Rack; Roland Goetz; Sebastian Soergel
- Web page: https://patentgrep.com/patent/US20210276959A1

## CPC

- C07D 237/20: Nitrogen atoms (nitro radicals C07D237/12)
- C07B 31/00: Reduction in general
- C07B 39/00: Halogenation
- C07B 43/04: of amino groups
- C07D 237/12: Halogen atoms or nitro radicals
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

Provided herein is a process for preparing a pyridazine amine compound of formula V, and a process for preparing dichloropyridazine amine compounds of formula IVa, IVb, and mixtures thereof. Further, provided herein are dichloropyridazine amine compounds of formula IVa, IVb, and mixtures thereof, wherein the amino group is an ethylamino group.

## Claims

### Claim 1

A process for preparing a pyridazine amine compound of formula V or a salt, tautomer, or N-oxide thereof
comprising the step of reacting (a) a dichloropyridazine amine compound of formula IVa or a salt, tautomer, or N-oxide thereof, or (b) a dichloropyridazine amine compound of formula IVb or a salt, tautomer or N-oxide thereof, or (c) a mixture of (a) and (b)
with hydrogen in the presence of a hydrogenation catalyst,
wherein
R1 is CH2CH3.

### Claim 2 (depends on 1)

The process according to claim 1, wherein the reaction is performed in the absence of a HCl scavenger.

### Claim 3 (depends on 1)

The process according to claim 1, wherein an HCl scavenger is added after removal of the hydrogenation catalyst, and wherein the HCl scavenger is provided without water.

### Claim 4 (depends on 3)

The process according to claim 3, wherein the HCl scavenger is selected from the group consisting of bases including alkali metal and alkaline earth metal hydroxides, alkali metal and alkaline earth metal oxides, alkali metal and alkaline earth metal hydrides, alkali metal amides, alkali metal and alkaline earth metal carbonates, alkali metal bicarbonates, alkali metal alkyls, alkylmagnesium halides, alkali metal and alkaline earth metal alcoholates, nitrogen containing bases including tertiary amines, pyridines, bicyclic amines, ammonia, and primary amines, and combinations thereof; buffers including sodium acetate and/or ammonium formate; precursors of ionic liquids including imidazoles; and combinations thereof.

### Claim 5 (depends on 1)

The process according to claim 1, wherein the hydrogenation catalyst is selected from the group consisting of platinum or palladium on a carrier, Raney nickel, and Raney cobalt, and is preferably platinum or palladium on carbon.

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The process according to claim 1, wherein the process further comprises the step of preparing (a) the dichloropyridazine amine compound of formula IVa or a salt, tautomer, or N-oxide thereof, or (b) the dichloropyridazine amine compound of formula IVb or a salt, tautomer, or N-oxide thereof, or (c) the mixture of (a) and (b)
in a one-pot reaction comprising the steps of
reacting a compound of formula II
with POCl3, and
reacting a resulting crude reaction product with an amine compound R1—NH2 or a salt thereof, wherein R1 is as defined in claim 1.

### Claim 8 (depends on 1)

The process according to claim 1, wherein the process further comprises the step of preparing (a) the dichloropyridazine amine compound of formula IVa or a salt, tautomer, or N-oxide thereof, or (b) the dichloropyridazine amine compound of formula IVb or a salt, tautomer, or N-oxide thereof, or (c) the mixture of (a) and (b)
by reacting a trichloropyridazine compound of formula III
with an amine compound R1—NH2 or a salt thereof, wherein R1 is as defined in claim 1,
and wherein the process optionally further comprises the step of preparing the trichloropyridazine compound of formula III
by reacting a compound of formula II
with POCl3.

### Claim 9 (depends on 7)

The process according to claim 7, wherein the process further comprises the step of preparing the compound of formula II
by reacting mucochloric acid (I)
with hydrazine or a salt thereof.

### Claim 10 (depends on 1)

The process according to claim 1, wherein the process further comprises the step of converting the pyridazine amine compound of formula V or a salt, tautomer, or N-oxide thereof into a compound of formula VII or a stereoisomer, salt, tautomer, or N-oxide thereof
by reacting the pyridazine amine compound of formula V or a salt, tautomer, or N-oxide thereof
with a compound of formula VI or a stereoisomer, salt, tautomer, or N-oxide thereof
wherein R1 is as defined in claim 1;
and wherein
R2 is H, halogen, CN, NO2, C1-C10-alkyl, C2-C10-alkenyl, or C2-C10-alkynyl, wherein the 3 last mentioned radicals may be unsubstituted, may be partially or fully halogenated or may carry 1, 2 or 3 identical or different substituents Rx, or ORa, SRa, C(Y)Rb, C(Y)ORc, S(O)Rd, S(O)2Rd, NReRf, C(Y)NRgRh, heterocyclyl, hetaryl, C3-C10-cycloalkyl, C3-C10-cycloalkenyl or phenyl, wherein the five last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4 or 5 identical or different substituents selected from the radicals Ry and Rx;
R3 is H, halogen, CN, NO2, C1-C10-alkyl, C2-C10-alkenyl, or C2-C10-alkynyl, wherein the 3 last mentioned radicals may be unsubstituted, may be partially or fully halogenated or may carry 1, 2 or 3 identical or different substituents Rx, or ORa, SRa, C(Y)Rb, C(Y)ORc, S(O)Rd, S(O)2Rd, NReRf, C(Y)NRgRh, heterocyclyl, hetaryl, C3-C10-cycloalkyl, C3-C10-cycloalkenyl or phenyl, wherein the five last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4 or 5 identical or different substituents selected from the radicals Ry and Rx;
RN is H, CN, NO2, C1-C10-alkyl, C2-C10-alkenyl, or C2-C10-alkynyl, wherein the three last mentioned radicals may be unsubstituted, may be partially or fully halogenated or may carry 1, 2 or 3 identical or different substituents Rx, or ORa, SRa, C(Y)Rb, C(Y)ORc, S(O)Rd, S(O)2Rd, NReRf, C(Y)NRgRh, S(O)mNReRf, C(Y)NR′NReRf, C1-C5-alkylen-OR3, C1-C5-alkylen-CN, C1-C5-alkylen-C(Y)Rb, C1-C5-alkylen-C(Y)ORc, C1-C5-alkylen-NReRf, C1-C5-alkylen-C(Y)NRgRh, C1-C5-alkylen-S(O)mRd, C1-C5-alkylen-S(O)mNReRf, C1-C5-alkylen-NR′NReRf, heterocyclyl, hetaryl, C3-C10-cycloalkyl, C3-C10-cycloalkenyl, heterocyclyl-C1-C5-alkyl, hetaryl-C1-C5-alkyl, C3-C10-cycloalkyl-C1-C5-alkyl, C3-C10-cycloalkenyl-C1-C5-alkyl, phenyl-C1-C5-alkyl, or phenyl, wherein the rings of the ten last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4 or 5 identical or different substituents Ry;
and wherein
Ra, Rb, Rc are independently of each other selected from H, C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C1-C4-alkoxy-C1-C4-alkyl, heterocyclyl, heterocyclyl-C1-C4-alkyl, phenyl, hetaryl, phenyl-C1-C4-alkyl, and hetaryl-C1-C4-alkyl, wherein the ring in the six last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4, or 5 substituents which, independently of each other, are selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy;
Rd is selected from C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C1-C4-alkoxy-C1-C4-alkyl, heterocyclyl, heterocyclyl-C1-C4-alkyl, phenyl, hetaryl, phenyl-C1-C4-alkyl, and hetaryl-C1-C4-alkyl, wherein the ring in the six last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4, or 5 substituents which are independently of each other selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy;
Re, Rf are independently of each other selected from H, C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C1-C4-alkoxy-C1-C4-alkyl, C1-C4-alkylcarbonyl, C1-C4-haloalkylcarbonyl, C1-C4-alkylsulfonyl, C1-C4-haloalkylsulfonyl, heterocyclyl, heterocyclyl-C1-C4-alkyl, heterocyclylcarbonyl, heterocyclylsulfonyl, phenyl, phenylcarbonyl, phenylsulfonyl, hetaryl, hetarylcarbonyl, hetarylsulfonyl, phenyl-C1-C4-alkyl, and hetaryl-C1-C4-alkyl, wherein the ring in the twelve last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4, or 5 substituents which, independently of each other, are selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy; or
Re and Rf together with the nitrogen atom to which they are bound form a 5- or 6-membered, saturated or unsaturated heterocycle, which may carry a further heteroatom being selected from O, S and N as a ring member atom and wherein the heterocycle may be unsubstituted or may carry 1, 2, 3, 4, or 5 substituents which are independently of each other selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy;
Rg, Rh are independently of each other selected from H, C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C1-C4-alkoxy-C1-C4-alkyl, heterocyclyl, heterocyclyl-C1-C4-alkyl, phenyl, hetaryl, phenyl-C1-C4-alkyl, and hetaryl-C1-C4-alkyl, wherein the ring in the six last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4, or 5 substituents which are independently of each other selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy;
Ri is selected from H, C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C1-C4-alkoxy-C1-C4-alkyl, phenyl, and phenyl-C1-C4-alkyl, wherein the phenyl ring in the two last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4, or 5 substituents which are independently of each other selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy;
Rx is selected from CN, NO2, C1-C4-alkoxy, C1-C4-haloalkoxy, S(O)mRd, S(O)mNReRf, C1-C10-alkylcarbonyl, C1-C4-haloalkylcarbonyl, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, C3-C6-cycloalkyl, 5- to 7-membered heterocyclyl, 5- or 6-membered hetaryl, phenyl, C3-C6-cycloalkoxy, 3- to 6-membered heterocyclyloxy, and phenoxy, wherein the last 7 mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4, or 5 radicals Ry;
Ry is selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, S(O)mRd, S(O)mNReRf, C1-C4-alkylcarbonyl, C1-C4-haloalkylcarbonyl, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C1-C4-alkoxy-C1-C4-alkyl;
and wherein
Y is O or S; and
m is 0, 1 or 2;
and wherein
X1 is a leaving group.

### Claim 11 (depends on 10)

The process according to claim 10, wherein
R2 is C1-C4-alkyl, which may be unsubstituted, or may be partially or fully halogenated;
R3 is H;
and wherein
RN is a group —CR4R5R6
wherein
R4 is selected from C1-C4-alkyl, which may be unsubstituted, may be partially or fully halogenated, or may carry 1 or 2 identical or different substituents Rx, wherein Rx is selected from CN and C(O)NH2, and C3-C6-cycloalkyl, which may be unsubstituted or may carry 1, 2, or 3 identical or different substituents Ry, wherein Ry is selected from halogen, CN and C(O)NH2; and
R5 is selected from C1-C4-alkyl, which may be unsubstituted, may be partially or fully halogenated, or may carry 1 or 2 identical or different substituents Rx, wherein Rx is selected from CN and C(O)NH2, and C3-C6-cycloalkyl, which may be unsubstituted or may carry 1, 2 or 3 identical or different substituents Ry, wherein Ry is selected from halogen, CN and C(O)NH2;
or
R4 and R5 together with the carbon atom to which they are attached form a 3- to 12-membered non-aromatic, saturated carbocycle, which may be partially or fully substituted by Rj, wherein Rj is selected from halogen, CN, and C(O)NH2, and
R6 is H;
and wherein
X1 preferably selected from halogen, N3, p-nitrophenoxy, and pentafluorophenoxy.

### Claim 12

A process for preparing (a) a dichloropyridazine amine compound of formula IVa or a salt, tautomer, or N-oxide thereof, or (b) a dichloropyridazine amine compound of formula IVb or a salt, tautomer, or N-oxide thereof, or (c) a mixture of (a) and (b)
in a one-pot reaction comprising steps of
reacting a compound of formula II
with POCl3, and
reacting the resulting crude reaction product with an amine compound R1—NH2 or a salt thereof, wherein R1 is CH2CH3.

### Claim 13

(canceled)

### Claim 14 (depends on 12)

The process according to claim 12, wherein the process further comprises the step of preparing a compound of formula II
by reacting mucochloric acid (I)
with hydrazine and a salt thereof.

### Claim 15 (depends on 12)

The process according to claim 12 wherein the process further comprises the step of converting (a) the dichloropyridazine amine compound of formula IVa or a salt, tautomer, or N-oxide thereof, or (b) the dichloropyridazine amine compound of formula IVb or a salt, tautomer, or N-oxide thereof, or (c) the mixture of (a) and (b) into a pyridazine amine compound of formula V or a salt, tautomer, or N-oxide thereof
by reacting (a) the dichloropyridazine amine compound of formula IVa or a salt, tautomer, or N-oxide thereof, or (b) the dichloropyridazine amine compound of formula IVb or a salt, tautomer, or N-oxide thereof, or (c) the mixture of (a) and (b)
with hydrogen in the presence of a hydrogenation catalyst, wherein R1 is as defined in claim 12;
wherein the process optionally further comprises the step of converting the pyridazine amine compound of formula V or a salt, tautomer, or N-oxide thereof into a compound of formula VII or a stereoisomer, salt, tautomer, or N-oxide thereof
by reacting the pyridazine amine compound of formula V or a salt, tautomer, or N-oxide thereof
with a compound of formula VI or a stereoisomer, salt, tautomer, or N-oxide thereof
wherein R1 is as defined in claim 12;
wherein
R2 is H, halogen, CN, NO2, C1-C10-alkyl, C2-C10-alkenyl, or C2-C10-alkynyl, wherein the 3 last mentioned radicals may be unsubstituted, may be partially or fully halogenated or may carry 1, 2 or 3 identical or different substituents Rx, or ORa, SRa, C(Y)Rb, C(Y)ORc, S(O)Rd, S(O)2Rd, NReRf, C(Y)NRgRh, heterocyclyl, hetaryl, C3-C10-cycloalkyl, C3-C10-cycloalkenyl or phenyl, wherein the five last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4 or 5 identical or different substituents selected from the radicals Ry and Rx;
R3 is H, halogen, CN, NO2, C1-C10-alkyl, C2-C10-alkenyl, or C2-C10-alkynyl, wherein the 3 last mentioned radicals may be unsubstituted, may be partially or fully halogenated or may carry 1, 2 or 3 identical or different substituents Rx, or ORa, SRa, C(Y)Rb, C(Y)ORc, S(O)Rd, S(O)2Rd, NReRf, C(Y)NRgRh, heterocyclyl, hetaryl, C3-C10-cycloalkyl, C3-C10-cycloalkenyl or phenyl, wherein the five last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4 or 5 identical or different substituents selected from the radicals Ry and Rx;
RN is H, CN, NO2, C1-C10-alkyl, C2-C10-alkenyl, or C2-C10-alkynyl, wherein the three last mentioned radicals may be unsubstituted, may be partially or fully halogenated or may carry 1, 2 or 3 identical or different substituents Rx, or ORa, SRa, C(Y)Rb, C(Y)ORc, S(O)Rd, S(O)2Rd, NReRf, C(Y)NRgRh, S(O)mNReRf, C(Y)NRiNReRf, C1-C5-alkylen-ORa, C1-C5-alkylen-CN, C1-C5-alkylen-C(Y)Rb, C1-C5-alkylen-C(Y)ORc, C1-C5-alkylen-NReRf, C1-C5-alkylen-C(Y)NRgRh, C1-C5-alkylen-S(O)mRd, C1-C5-alkylen-S(O)mNReRf, C1-C5-alkylen-NRiNReRf, heterocyclyl, hetaryl, C3-C10-cycloalkyl, C3-C10-cycloalkenyl, heterocyclyl-C1-C5-alkyl, hetaryl-C1-C5-alkyl, C3-C10-cycloalkyl-C1-C5-alkyl, C3-C10-cycloalkenyl-C1-C5-alkyl, phenyl-C1-C5-alkyl, or phenyl, wherein the rings of the ten last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4 or 5 identical or different substituents Ry;
and wherein
Ra, Rb, Rc are independently of each other selected from H, C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C1-C4-alkoxy-C1-C4-alkyl, heterocyclyl, heterocyclyl-C1-C4-alkyl, phenyl, hetaryl, phenyl-C1-C4-alkyl, and hetaryl-C1-C4-alkyl, wherein the ring in the six last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4, or 5 substituents which, independently of each other, are selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy;
Rd is selected from C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C1-C4-alkoxy-C1-C4-alkyl, heterocyclyl, heterocyclyl-C1-C4-alkyl, phenyl, hetaryl, phenyl-C1-C4-alkyl, and hetaryl-C1-C4-alkyl, wherein the ring in the six last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4, or 5 substituents which are independently of each other selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy;
Re, Rf are independently of each other selected from H, C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C1-C4-alkoxy-C1-C4-alkyl, C1-C4-alkylcarbonyl, C1-C4-haloalkylcarbonyl, C1-C4-alkylsulfonyl, C1-C4-haloalkylsulfonyl, heterocyclyl, heterocyclyl-C1-C4-alkyl, heterocyclylcarbonyl, heterocyclylsulfonyl, phenyl, Phenylcarbonyl, Phenylsulfonyl, hetaryl, hetarylcarbonyl, hetarylsulfonyl, phenyl-C1-C4-alkyl, and hetaryl-C1-C4-alkyl, wherein the ring in the twelve last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4, or 5 substituents which, independently of each other, are selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy; or
Re and Rf together with the nitrogen atom to which they are bound form a 5- or 6-membered, saturated or unsaturated heterocycle, which may carry a further heteroatom being selected from O, S and N as a ring member atom and wherein the heterocycle may be unsubstituted or may carry 1, 2, 3, 4, or 5 substituents which are independently of each other selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy;
Rg, Rh are independently of each other selected from H, C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C1-C4-alkoxy-C1-C4-alkyl, heterocyclyl, heterocyclyl-C1-C4-alkyl, phenyl, hetaryl, phenyl-C1-C4-alkyl, and hetaryl-C1-C4-alkyl, wherein the ring in the six last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4, or 5 substituents which are independently of each other selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy;
Ri is selected from H, C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C1-C4-alkoxy-C1-C4-alkyl, phenyl, and phenyl-C1-C4-alkyl, wherein the phenyl ring in the two last mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4, or 5 substituents which are independently of each other selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy;
Rx is selected from CN, NO2, C1-C4-alkoxy, C1-C4-haloalkoxy, S(O)mRd, S(O)mNReRf, C1-C10-alkylcarbonyl, C1-C4-haloalkylcarbonyl, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, C3-C6-cycloalkyl, 5- to 7-membered heterocyclyl, 5- or 6-membered hetaryl, phenyl, C3-C6-cycloalkoxy, 3- to 6-membered heterocyclyloxy, and phenoxy, wherein the last 7 mentioned radicals may be unsubstituted or may carry 1, 2, 3, 4, or 5 radicals Ry;
Ry is selected from halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, S(O)mRd, S(O)mNReRf, C1-C4-alkylcarbonyl, C1-C4-haloalkylcarbonyl, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C1-C4-alkoxy-C1-C4-alkyl;
and wherein
Y is O or S; and
m is 0, 1 or 2;
and wherein
X1 is a leaving group.

### Claim 16

(canceled)

### Claim 17

(canceled)
